-
TESARO Announces Closing of Public Offering of Common Stock and Exercise of Over-Allotment Option by Underwriters
-
TESARO (TSRO) Prices 3.4M Common Offering at $51/Share
-
TESARO Announces Pricing of Public Offering of Common Stock
-
TESARO (TSRO) Announces $150M Common Offering
-
TESARO Announces Closing of $201.25 Million Public Offering of 3.00% Convertible Senior Notes Due 2021, Including Full Exercise of the Underwriters' Option to Purchase Additional Notes
-
TESARO Announces Pricing of $175 Million of 3.00% Convertible Senior Notes Due 2021
-
TESARO Announces Offering of $165 Million of Convertible Senior Notes Due 2021
-
Streetinsider.com's Hot Lunchtime Reads 05/12: (SRC) (MSFT) (SSYS) (SUNE) (TSRO)
-
Tesaro (TSRO) PT Lifted to $66 at BMO Capital Amid Rolapitant Data
-
TESARO (TSRO) Prices 3.2M Shares at $31.50
-
TESARO Announces Pricing of Public Offering of Common Stock
-
Pre-Open Stock Movers 1/29: (VRNG) (FSL) (DOW) Higher; (PGNX) (TUP) (BA) Lower (more...)
-
After Hours Stock Movers 1/28: (EZPW) (VRNG) (MDVN) Higher; (AIRM) (CRUS) (YHOO) Lower (more...)
-
TESARO (TSRO) Announces $100M Common Stock Offering
-
TESARO Announces Proposed Public Offering of Common Stock
-
BMO Capital Upgrades Tesaro (TSRO) to Outperform
-
BMO Capital Downgrades Tesaro (TSRO) to Market Perform
-
TESARO (TSRO) Prices 4.72M Share Offering at $18
-
TESARO (TSRO) Announces $75M Common Offering
-
BMO Capital Starts Tesaro (TSRO) at Outperform
-
TESARO (TSRO) Sets IPO Price Range at $12-$15/Share
-
Oncology Biopharma TESARO (TSRO) Files $86.25M IPO